Mississippi’s medical cannabis program kicked off about a week ago and now thousands of patients across the state are legally purchasing marijuana to treat qualifying illnesses, including cancer, glaucoma, sickle cell anemia, seizures and chronic pain.A new partnership aims to find out how effective marijuana is at treating those conditions.“To be able to walk into a dispensary and know right off the bat what products are going to work for certain debilitating medical conditions,” said Angie Calhoun, with the Mississippi Cannabis Patients Alliance.The alliance announced Wednesday it is teaming up with the University of Mississippi, where the National Center for Cannabis Research and Education is housed.“Helping to kind of advance our knowledge base about how medical cannabis can be beneficial to patients and used effectively and safely,” said Larry Walker, with the University of Mississippi.The information analyzed by researchers will be collected through another member of the partnership: Releaf app, a marijuana treatment tracking platform that will collect a wide range of patient data.“What symptoms and conditions are patients using these products for? What’s the impact those products are having on the severity of their symptoms and condition? And what other feelings, side effects and emotions are they experiencing?” said Releaf COO Tyler Dautrich.Other states that have tried similar cannabis research programs haven’t been very successful. Supporters of the new Mississippi project hopes to build a better track record of success to give patients the best care.
Mississippi’s medical cannabis program kicked off about a week ago and now thousands of patients across the state are legally purchasing marijuana to treat qualifying illnesses, including cancer, glaucoma, sickle cell anemia, seizures and chronic pain.
Advertisement
A new partnership aims to find out how effective marijuana is at treating those conditions.
“To be able to walk into a dispensary and know right off the bat what products are going to work for certain debilitating medical conditions,” said Angie Calhoun, with the Mississippi Cannabis Patients Alliance.
The alliance announced Wednesday it is teaming up with the University of Mississippi, where the National Center for Cannabis Research and Education is housed.
“Helping to kind of advance our knowledge base about how medical cannabis can be beneficial to patients and used effectively and safely,” said Larry Walker, with the University of Mississippi.
The information analyzed by researchers will be collected through another member of the partnership: Releaf app, a marijuana treatment tracking platform that will collect a wide range of patient data.
“What symptoms and conditions are patients using these products for? What’s the impact those products are having on the severity of their symptoms and condition? And what other feelings, side effects and emotions are they experiencing?” said Releaf COO Tyler Dautrich.
Other states that have tried similar cannabis research programs haven’t been very successful. Supporters of the new Mississippi project hopes to build a better track record of success to give patients the best care.
